To identify the set of potential intestinal bacteria contributing to obesity or to obesity with metabolic complications, namely, IR, we established correlations between abundances of selected OTUs and fecal immune markers that discriminate among the study groups, including MCP-1, IFN-γ, or TNF-α (Fig. 3A and B). This evidence concerns the gene CCL2 and obesity disorder.